RU2009119825A - PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ALLERGIC AND INFLAMMATORY DISEASES OF THE SKIN - Google Patents
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ALLERGIC AND INFLAMMATORY DISEASES OF THE SKIN Download PDFInfo
- Publication number
- RU2009119825A RU2009119825A RU2009119825/15A RU2009119825A RU2009119825A RU 2009119825 A RU2009119825 A RU 2009119825A RU 2009119825/15 A RU2009119825/15 A RU 2009119825/15A RU 2009119825 A RU2009119825 A RU 2009119825A RU 2009119825 A RU2009119825 A RU 2009119825A
- Authority
- RU
- Russia
- Prior art keywords
- pharmaceutical composition
- derivatives
- molecular weight
- high molecular
- glucocorticosteroid
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract 9
- 230000000172 allergic effect Effects 0.000 title claims abstract 3
- 208000010668 atopic eczema Diseases 0.000 title 1
- 208000027866 inflammatory disease Diseases 0.000 title 1
- 150000002605 large molecules Chemical class 0.000 claims abstract 7
- 239000003862 glucocorticoid Substances 0.000 claims abstract 6
- 239000003883 ointment base Substances 0.000 claims abstract 4
- 229920000642 polymer Polymers 0.000 claims abstract 4
- 229920001059 synthetic polymer Polymers 0.000 claims abstract 4
- 201000004624 Dermatitis Diseases 0.000 claims abstract 2
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 claims abstract 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims abstract 2
- 208000026935 allergic disease Diseases 0.000 claims abstract 2
- NBMKJKDGKREAPL-DVTGEIKXSA-N beclomethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O NBMKJKDGKREAPL-DVTGEIKXSA-N 0.000 claims abstract 2
- 229940092705 beclomethasone Drugs 0.000 claims abstract 2
- 229960002537 betamethasone Drugs 0.000 claims abstract 2
- UREBDLICKHMUKA-DVTGEIKXSA-N betamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-DVTGEIKXSA-N 0.000 claims abstract 2
- 229920001577 copolymer Polymers 0.000 claims abstract 2
- 239000006071 cream Substances 0.000 claims abstract 2
- 229960003957 dexamethasone Drugs 0.000 claims abstract 2
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 claims abstract 2
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 claims abstract 2
- 229960003469 flumetasone Drugs 0.000 claims abstract 2
- WXURHACBFYSXBI-GQKYHHCASA-N flumethasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]2(C)C[C@@H]1O WXURHACBFYSXBI-GQKYHHCASA-N 0.000 claims abstract 2
- 239000000499 gel Substances 0.000 claims abstract 2
- 239000000865 liniment Substances 0.000 claims abstract 2
- 229940040145 liniment Drugs 0.000 claims abstract 2
- 125000005395 methacrylic acid group Chemical class 0.000 claims abstract 2
- 229960001664 mometasone Drugs 0.000 claims abstract 2
- QLIIKPVHVRXHRI-CXSFZGCWSA-N mometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CCl)(O)[C@@]1(C)C[C@@H]2O QLIIKPVHVRXHRI-CXSFZGCWSA-N 0.000 claims abstract 2
- 239000002674 ointment Substances 0.000 claims abstract 2
- 229920002451 polyvinyl alcohol Polymers 0.000 claims abstract 2
- 235000019422 polyvinyl alcohol Nutrition 0.000 claims abstract 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims abstract 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims abstract 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims abstract 2
- 229910000077 silane Inorganic materials 0.000 claims abstract 2
- 229920002521 macromolecule Polymers 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1. Фармацевтическая композиция для наружного применения для лечения аллергических и воспалительных заболеваний кожи, содержащая глюкокортикостероид, высокомолекулярное соединение и мазевую основу, отличающаяся тем, что в качестве высокомолекулярного соединения она содержит синтетическое полимерное высокомолекулярное соединение, при следующем соотношении, мас.%: ! глюкокортикостероид 0,002-0,1 синтетическое полимерное высокомолекулярное соединение 0,5-15 мазевая основа до 100 ! 2. Фармацевтическая композиция по п.1, отличающаяся тем, что в качестве глюкокортикостероида она содержит, в частности мометазон или производные, бетаметазон или его производные, беклометазон или его производные, дексаметазон или его производные, флуметазон или его производные. ! 3. Фармацевтическая композиция по п.1, отличающаяся тем, что в качестве синтетического полимерного высокомолекулярного соединения она содержит поливинилпирролидон, полимеры и сополимеры акриловой и метакриловой кислот, поливиниловые спирты, силоксановые или силановые полимеры. ! 4. Фармацевтическая композиция по п.1, отличающаяся тем, что она выполнена в виде крема, геля, линимента или мази. 1. A pharmaceutical composition for external use for the treatment of allergic and inflammatory skin diseases, comprising a glucocorticosteroid, a high molecular weight compound and an ointment base, characterized in that it contains a high molecular weight synthetic polymer compound in the following ratio, wt.%:! glucocorticosteroid 0.002-0.1 synthetic polymeric high molecular weight compound 0.5-15 ointment base up to 100! 2. The pharmaceutical composition according to claim 1, characterized in that it contains, in particular, mometasone or derivatives, betamethasone or its derivatives, beclomethasone or its derivatives, dexamethasone or its derivatives, flumethasone or its derivatives, as glucocorticosteroid. ! 3. The pharmaceutical composition according to claim 1, characterized in that as a synthetic polymer high molecular weight compound it contains polyvinylpyrrolidone, polymers and copolymers of acrylic and methacrylic acids, polyvinyl alcohols, siloxane or silane polymers. ! 4. The pharmaceutical composition according to claim 1, characterized in that it is made in the form of a cream, gel, liniment or ointment.
Claims (4)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2009119825/15A RU2420266C2 (en) | 2009-05-25 | 2009-05-25 | Pharmaceutic composition for treatment of allergic and inflammatory skin diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2009119825/15A RU2420266C2 (en) | 2009-05-25 | 2009-05-25 | Pharmaceutic composition for treatment of allergic and inflammatory skin diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2009119825A true RU2009119825A (en) | 2010-11-27 |
| RU2420266C2 RU2420266C2 (en) | 2011-06-10 |
Family
ID=44057373
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2009119825/15A RU2420266C2 (en) | 2009-05-25 | 2009-05-25 | Pharmaceutic composition for treatment of allergic and inflammatory skin diseases |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2420266C2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2548764C2 (en) * | 2013-01-25 | 2015-04-20 | Открытое Акционерное Общество "Татхимфармпрепараты" | Medication for treating dermatosis (versions) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1140021B1 (en) * | 1998-12-23 | 2004-08-04 | Idea Ag | Improved formulation for topical non-invasive application in vivo |
| RU2220739C1 (en) * | 2002-08-30 | 2004-01-10 | Гапонюк Петр Яковлевич | Intranasal agent |
| WO2007064912A2 (en) * | 2005-12-02 | 2007-06-07 | Elan Pharma International Limited | Mometasone compositions and methods of making and using the same |
-
2009
- 2009-05-25 RU RU2009119825/15A patent/RU2420266C2/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2420266C2 (en) | 2011-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE495743T1 (en) | TRIAZOLOPYRIDINE COMPOUNDS FOR THE TREATMENT OF DEGENERATIONAL AND INFLAMMATORY DISEASES | |
| MX372534B (en) | POLYCYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE. | |
| MX2010009623A (en) | 1-benzyl-3-hydroxymethylindazoiî¹e derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1. | |
| ECSP10010352A (en) | QUITOSANE GEL FOR DERMATOLOGICAL APPLICATIONS, PROCESS FOR OBTAINING AND USING THE SAME | |
| EA201001324A1 (en) | GEL possessing anti-inflammatory and anti-allergic action | |
| MX2010009625A (en) | 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40. | |
| RU2015141767A (en) | Compositions and methods for the local delivery of prostaglandins to subcutaneous fat | |
| CN104645320A (en) | Mussel mucoprotein gel for wound repair, and preparation method and application thereof | |
| FI3691649T3 (en) | COMPOSITIONS AND METHODS FOR WOUND TREATMENT | |
| JP2013526594A (en) | Tamarind seed polysaccharide for use in the treatment of microbial infections | |
| WO2012177660A3 (en) | Leukotoxin e/d as a new anti-inflammatory agent and microbicide | |
| RU2009119825A (en) | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ALLERGIC AND INFLAMMATORY DISEASES OF THE SKIN | |
| WO2014182610A3 (en) | Alpha adrenergic agonists for in the treatment of tissue trauma | |
| RU2009141856A (en) | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ALLERGIC AND INFLAMMATORY DISEASES OF THE SKIN | |
| RU2008146608A (en) | HYDROPHILIC PHARMACEUTICAL COMPOSITION FOR TREATING BURNS (OPTIONS) | |
| RU2016116138A (en) | Pharmaceutical composition for treating wounds and burns | |
| RU2015115143A (en) | Wound healing gel for external use | |
| RU2008105588A (en) | Composition for the treatment of purulent wounds and trophic ulcers | |
| RU2013110452A (en) | CYTOKIN-CONTAINING MEDICINES PREVENTING ANTIVIRAL, ANTI-MICROBIAL, IMMUNOMODULATING AND ANTI-INFLAMMATORY ACTION FOR PREVENTION AND TREATMENT OF INFECTIOUS DISEASES | |
| RU2011124647A (en) | Ointment with extract of larvae of large wax moth and extract of propolis for prophylaxis and complex treatment of viral infection | |
| RU2017135878A (en) | DENTAL GEL FOR TREATMENT AND PREVENTION OF PERIODONTITIS | |
| RU2012152225A (en) | DENTAL PENCIL WITH CALCIUM NANOSUBSTANCE GLUCONATE FOR THE TREATMENT OF DISEASES CONNECTED WITH A DEFICIENCY OF CALCIUM | |
| RU2013135817A (en) | Means for the treatment of purulent-inflammatory processes of soft tissues and mucous membranes | |
| CO2018001531A2 (en) | Lisobactin for use in the treatment of bovine mastitis | |
| EA200800987A1 (en) | 1,3-DIALKYLBENZIMIDAZOLIYA HALOGENIDES, HAVING REGENERATIVE, ANTI-INFLAMMATORY AND ANTI-MICROSOUS ACTIVITY |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC41 | Official registration of the transfer of exclusive right |
Effective date: 20111229 |
|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20200526 |